USPTO serial 76705415
CLINPATH
Reviewed by CopyMark Law Group
Reg. 4017447Status 710
- Filing date
- Status date
- Registration date
- Aug 30, 2011
- Examiner
- HALMEN, KATHERINE E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with CLINPATH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert J. Diettrich
ROBERT J. DIETTRICH Davis, Malm & D'Agostine, P.C.1 BOSTON PL STE 3700BOSTON, MA 02108-4470UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consultation and business information management services in the fields of biotechnology, pharmaceutical drug and device development and clinical trials, namely, clinical data and regulatory submission management for biotech, pharmaceutical and medical device companies to assist them with clinical research, clinical trials and applications for drug, biologic and medical device approval | SECTION 8 - CANCELLED | Aug 31, 2010 |
| 042 | Consulting services in the fields of biotechnology, pharmaceutical drug and device development; clinical research and development, namely, conducting clinical trials in the fields of biotechnology, pharmaceutical drug and device development for supporting regulatory filings for pharmaceutical drugs, biologics and medical devices; providing strategic clinical development program evaluation and implementation support for generating and supporting regulatory filings for pharmaceutical drugs, biologics and medical devices, namely, technical writing for biotech, pharmaceutical and medical device companies, clinical research and development in the nature of conducting clinical trials in the fields of biotechnology, pharmaceutical drug and device development, quality evaluation services for the biotech, pharmaceutical and medical device industries, and consultation services in the fields of biotechnology, pharmaceutical drug and device development; consulting services in the fields of biotechnology, pharmaceutical drug and device development; clinical research and development, namely, conducting medical and pharmaceutical clinical trials covering all aspects of drug, biologic and device development tasks; clinical research and development, namely, conducting clinical trials and providing consultation services in the fields of pharmaceutical drugs, biologics and medical devices | SECTION 8 - CANCELLED | Aug 31, 2010 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 6, 2018 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 30, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 14, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 25, 2011 | NPUB | NOTICE OF PUBLICATION | — |
| May 6, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 6, 2011 | ALIE | ASSIGNED TO LIE | — |
| Apr 21, 2011 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Apr 21, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 21, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 21, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 8, 2011 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 8, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 1, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 27, 2010 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 23, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |